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communities and in immigrant
endemic countries.2 After suc
lobbying by NT clinicians for re
tion of albendazole in Aust
instead of the inferior pyrant
Indigenous community chil
deworming program (CCDP)5) · 18 March 2013Objectives:  To determine the prevalence and trends of human hookworm 
infection (HWI) in the Northern Territory over the past 10 years, and to assess 
the influence of the community children’s deworming program (CCDP).
Design, patients and setting:  A retrospective observational analysis of 
consecutive microbiologically confirmed cases of HWI in patients diagnosed at 
NT government health care facilities and the main private laboratory servicing 
the NT between January 2002 and July 2012.
Main outcome measures:  Annual prevalence of HWI (2002–2011); age, sex, 
Indigenous status, residence, haemoglobin level and eosinophil count of 
patients with HWI; and proportion of patients within the CCDP target population 
(children aged 6 months to 16 years, who should receive 6-monthly 
albendazole).
Results:  From 64 691 faecal samples examined during the study period, 
hookworm was detected in 112 patients. There was a downward trend in the 
annual prevalence of HWI, falling from 14.0 cases per 100 000 population (95% 
CI, 8.8–19.2) in 2002 to 2.2 per 100 000 population (95% CI, 0.3–4.1) in 2011. 
Only 16 patients (14.3%) fell within the CCDP target population. Seventy-one 
patients (63.4%) were living in remote communities, and 94 (84.7%) were 
recorded as Indigenous Australians.
Conclusions:  The prevalence of HWI in the NT reduced over the 10-year period. 
HWI predominantly occurs in individuals outside the CCDP target population. 
Our data support continuation of the CCDP in conjunction with improvements in 
housing, health hardware and health promotion. Continued use of albendazole 
in individuals beyond the CCDP may facilitate the eventual eradication of HWI 
from the NT.
Abstractoo
de
are
lion peop
H kworms (Ancylostoma duo-nale and Necator americanus) thought to infect 740 mil-
le worldwide.1 Most infec-
tions occur in low- and middle-
income countries where the root
causes are socioeconomic vulnerabil-
ity and limited access to safe water,
good hygiene and adequate sanita-
tion. Hookworm, along with other
soil-transmitted helminthiases, is
included in the World Health Organi-
zation category of neglected tropical
diseases. A. duodenale is thought to be
the exclusive species in the Northern
Territory and is associated with the
greatest intestinal blood loss.2,3
The major consequence of hook-
worm infection (HWI) is iron-defi-
ciency anaemia, which is responsible
for significant morbidity, particularly
in children and pregnant women. In
children, HWI is associated with
impaired nutritional status and physi-
cal and mental development.4 HWI is
considered a public health problem in
a country when the prevalence of
infection in children aged 1–14 years
is > 1%. The WHO’s 2010 global tar-
get of 75% coverage of preventive
chemotherapy or “deworming” in
such countries was not met and has
been extended to 2020.1 A recent
Cochrane review concluded that the
evidence base supporting the effec-
tiveness of routine deworming pro-
grams was small and insufficient
using Cochrane principles,5 but there
is considerable historical support for
the role of mass drug therapy for
HWI, in parallel with sanitation and
hygiene initiatives.1
Although virtually eradicated from
the non-Indigenous Australian popu-
lation by the 1960s, HWI has persisted
in Indigenous Australians in remote
s from
cessful
gistra-
ralia,6
el, the
dren’s
 with
albendazole commenced in 1995 in
the NT.7 The Central Australian Rural
Practitioners Association (CARPA)
Standard treatment manual recom-
mends that in areas where HWI is
common, children aged 6 months to
16 years should have a single dose of
albendazole twice a year (or pyrantel
if pregnant).8 It suggests administra-
tion either side of the wet season, in
conjunction with routine child health
assessments or school-age screening.
Recent epidemiological data on the
prevalence of HWI in the NT are not
available,9 and there are no published
data on the implementation and
effectiveness of the CCDP. The objec-
tives of this study were to determine
the prevalence and trends of human
HWI in the NT over the past 10 years
and to assess the influence of the
CCDP.
Methods
We conducted a retrospective obser-
vational analysis of consecutive
microbiologically confirmed cases of
HWI in the NT between January 2002
and July 2012. Ethics approval for the
study was obtained from the Human
Research Ethics Committee of the NT
Department of Health and Menzies
School of Health Research (HREC-
2012-1842).
Data collection
Cases were identified from the NT
government pathology laboratories
information system, LabTrak, which
covers all NT government health care
facilities, including five hospitals, two
correctional centres and more than 50
remote clinics, that collectively serve a
current population of about 235 000.10
We also identified cases from data
obtained from Western Diagnostic
Pathology, the major private provider
of pathology services to remote clinics
and Aboriginal community-controlled
health services in the NT. Data were
not available from the two other pri-
vate providers of pathology services to
the NT. Each pathology laboratory
examined faecal specimens for hook-
worm eggs by wet mount microscopy
and a concentration method.11
Data on identified HWI cases were
linked to NT government electronic
health records by medical record
number to collect information on
Researchpatients’ age, sex, Indigenous status,
residence, haemoglobin level and
eosinophil count at the time of diag-
nosis. Residence was determined from
residential address, and remote
(including very remote) areas of resi-
dence were defined as per the Aus-
tra l ian S tandard Geographica l
Classification.12 Anaemia was defined
as a haemoglobin level < 110 g/L, and
eosinophilia as an eosinophil count
 0.5  109/L.8 We were unable to
obtain data on anthelmintic treatment
for individual patients. Attempts to
obtain robust data regarding numbers
of doses of albendazole dispensed per
community clinic for the CCDP were
not successful.
Statistical analysis
Data were entered into a Microsoft
Access 2007 database and analysed
using Stata, version 10 (StataCorp).
Descriptive statistics are presented for
all patients with HWI between January
2002 and July 2012. Differences
between adults and children were
determined using the Fisher exact test
for categorical variables (sex, Indige-
nous status, residence) and Mann–
Whitney tests for continuous non-nor-
mally distributed variables (haemo-
globin level and eosinophil count).
Level of significance was set at P < 0.05.
The estimated annual prevalences
for 2002 to 2011 are expressed as cases
per 100 000 population, with 95%
confidence intervals. The estimated
prevalence for 2012 could not be cal-
culated as the dataset only included
cases up to the end of July. The esti-
mated annual resident population for
the NT was obtained from the Aus-
tralian Bureau of Statistics.10
Results
From a total of 64 691 faecal speci-
mens examined during the period
January 2002 – July 2012, hookworm
eggs were identified in 134 samples
from 112 patients. Four patients had a
second positive faecal sample, all
occurring within 8 months of the first
detection.
The annual number of faecal sam-
ples tested across all NT laboratories
was relatively constant, with a median
of 5807 from 2002 to 2011 (range,
5379–9785). Only six patients (5.4%)
were diagnosed at Western Diagnos-
tic Pathology, with the remainder
diagnosed at government laborato-
ries: 87 (77.7%) at Royal Darwin Hos-
pital, 14 (12.5%) at Alice Springs
Hospital, and five (4.5%) at district
laboratories. All patients except the
six diagnosed at Western Diagnostic
Pathology were in hospital at the time
of diagnosis. The details of the West-
ern Diagnostic Pathology cases were
incomplete, but three diagnoses were
in Indigenous people living in remote
communities.
The demographic characteristics,
haemoglobin level and eosinophil
count of the patients are shown in
Box 1, stratified by age group. There
were no statistical differences in
Indigenous status or sex between
children and adults in the sample, but
there was a difference in residence.
Median eosinophil count was signifi-
cantly higher in children than in
adults, but there was no significant
difference in haemoglobin levels.
Most patients (94; 84.7%) were
Indigenous. Seventy-one patients
(63.4%) resided in remote areas, of
whom 69 were Indigenous. Of the 17
children, 16 were Indigenous and one
was from Sudan. All of the Indige-
nous children resided in remote com-
munities. Twelve of the 13 patients
from overseas were from Indonesia.
Eleven patients (9.8%) were of no
fixed abode in Darwin (all Indige-
nous), and 23 (20.5%) were diagnosed
in prison facilities.
Ninety and 89 of the 112 patients
had data available for haemoglobin
level and eosinophil count, respec-
tively. Sixty (66.7%) were anaemic
and 65 (73.0%) had eosinophilia. Of
note, no children and only four adults
had neither of these markers present.
The annual prevalence of HWI by
age, and the proportion of total faecal
samples positive for hookworm are
shown in Box 2, with the numbers of
cases and population data in Box 3.
The estimated prevalence fell rela-
tively steadily over time, from 14.0 per
100 000 population (95% CI, 8.8–19.2)
in 2002 to 2.2 per 100 000 population
(95% CI, 0.3–4.1) in 2011.
Only 16 patients (14.3%) were in
the target age range of the CCDP (6
months to 16 years). The one remain-
ing child was under 6 months of age
(5 months old and diagnosed in 2002).
There have been only two cases of
HWI in the < 17-years age group since
2007 and none since 2010 (Box 3).
Discussion
We found a clear and consistent
reduction in the number of microbio-
1 Demographic and laboratory parameters of patients with hookworm infection, 
Northern Territory, January 2002 – July 2012
Age group
Parameter All patients < 17 years  17 years P
Number 112 ( 17 (15.2%) 95 (84.8%)
Sex 0.60
Female 51 (45.5%) 9 (52.9%) 42 (44.2%)
Male 61 (54.5%) 8 (47.1%) 53 (55.8%)
Indigenous status* 0.46
Indigenous 94 (84.7%) 16 (94.1%) 78 (83.0%)
Non-Indigenous 17 (15.3%) 1 (5.9%) 16 (17.0%)
Patient residence† 0.03
Urban 23 (20.5%) 0 ( 23 (24.2%)
Remote 71 (63.4%) 16 (94.1%) 55 (57.9%)
Overseas 13 (11.6%) 1 (5.9%) 12 (12.6%)
Unknown 5 (4.5%) 0 ( 5 (5.3%)
Anaemia‡ 60 (66.7%) 12 (75.0%) 48 (64.9%)
Median haemoglobin, g/L (IQR)‡ 94 (75–120) 91 (56–108) 94 (76–122) 0.18
Eosinophilia§ 65 (73.0%) 12 (75.0%) 53 (72.6%)
Median eosinophil count,  109/L (IQR)§ 1.1 (0.3–1.8) 1.9 (0.8–3.4) 0.9 (0.3–1.6) 0.02
IQR = interquartile range. * Defined as Aboriginal or Torres Strait Islander. Indigenous status was 
not available for one patient aged  17 years. † Deﬁned by Australian Standard Geographical 
Classification.12 ‡ Anaemia deﬁned as haemoglobin level < 110 g/L. Data available for 90 patients 
(16 patients < 17 years and 74 patients  17 years). § Eosinophilia defined as an eosinophil count 
0.5  109/L. Data available for 89 patients (16 patients < 17 years and 73 patients  17 years). ◆279MJA 198 (5) · 18 March 2013
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3 Annual hookworm
Age < 17 years 
Cases (n= 17)
Population‡
Prevalence*
Age  17 years 
Cases (n= 95)
Population‡
Prevalence*
All patients 
Cases (n= 112)
Population‡
Prevalence* 
(95% CI) (
* Prevalence per 100 00
Bureau of Statistics.10 logically confirmed cases of HWI
occurring in the NT from January 2002
to July 2012. Microbiologically con-
firmed HWI is now a rare event in the
NT and occurs mainly in individuals
outside the CCDP target group, par-
ticularly in adults, prisoners and
homeless urban Indigenous people.
The epidemiology of HWI in Aus-
tralia has been poorly documented
since a national hookworm campaign
and survey in 1919–1924 demon-
strated a prevalence of 10.7% (14 067/
130 833) in endemic areas.2 The cam-
paign, which involved treatment,
health education and improving sani-
tation, was focused on non-Indige-
n o us Au st ra l i a n s  an d  led  to
eradication from this population. The
prevalence of HWI in the NT was 17%
in the 1924 survey (from 886 faecal
samples),2 and 25% in a 1994 survey
(from 300 samples) in a remote Indig-
enous community in east Arnhem
Land (Aland K, Prociv P, Currie B,
Jones H. Intestinal parasite infections
and anaemia in Arnhem Land Abo-
riginal community [unpublished
abstract]. Australian Tropical Health
and Nutrition Conference; Brisbane,
Qld; 17–19 July 1997). We found the
prevalence of HWI in the NT in 2011
had dropped to 2.2%. This reduction
has occurred since the commence-
ment of the albendazole-based CCDP
in 1995, and extremely low rates of
HWI are now seen in its target popu-
lation. However, the magnitude of the
effect of the CCDP remains uncertain,
as its implementation and coverage at
community or regional level has never
been monitored or evaluated.
In contrast to other soil-transmit-
ted helminthiases in which the high-
est intensity and prevalence of
infections occur in school-aged chil-
dren, high-intensity HWIs predomi-
nantly occur in adults.3,13 In 1992, a
survey in an isolated community in
northern Western Australia found
HWI prevalences of 93% in children
aged 5–14 years and 77% overall.14
After implementation of a hookworm
control program, in which regular
albendazole was given to children
every 6 months and to adults annu-
ally, along with health education and
environmental management meas-
ures, the overall HWI prevalence rate
fell from 80% in 1993 to 2.6% in
1999.15 In our NT data, there was a
marked reduction in the prevalence of
adult HWI from 2002, despite adults
not being targeted in the CCDP. This
could in part be attributable to a car-
ryover effect from early intense alben-
dazole use in the CCDP in the 1990s
and/or the common use of albenda-
zole in the NT for individuals with
anaemia or eosinophilia.8 The CARPA
manual recommends empirical treat-
ment with 3 days of albendazole (for
hookworm, Trichuris trichiura and
Strongyloides stercoralis infection) for
anaemia, failure to thrive and signifi-
cant diarrhoea in children.8
Our retrospective study has several
limitations. The true prevalence rates
are likely to have been underesti-
mated, as systematic sampling was
not undertaken. All except six patients
were diagnosed in hospital, reflecting
a selection bias towards individuals
who seek health care, are acutely ill or
 infection cases and prevalence,* by age group, Northern Territory, 2002–2012
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012†
1 5 4 3 2 0 1 0 1 0 0
56 990 56 993 57 123 57 669 58 159 58 280 58 721 59 263 59 316 58 935 59 232
1.8 8.8 7.0 5.2 3.4 0.0 1.7 0.0 1.7 0.0 0.0
27 8 18 9 4 6 4 5 4 5 5
142 421 143 113 144 940 148 704 152 468 156 741 162 214 167 578 170 999 172 396 175 604
19.0 5.6 12.4 6.1 2.6 3.8 2.5 3.0 2.3 2.9 2.8
28 13 22 12 6 6 5 5 5 5 5
199 411 200 106 204 919 206 373 210 627 215 021 220 935 226 841 230 315 231 331 234 836
14.0 
8.8–19.2)
6.5 
(3.0–10.0)
10.9 
(6.3–15.4)
5.8 
(2.5–9.1)
2.8 
(0.6–5.1)
2.8
(0.6–5.0)
2.3 
(0.3–4.3)
2.2
(0.3–4.1)
2.2 
(0.3–4.1)
2.2 
(0.3–4.1)
2.1 
(0.3–4.0)
0 population. † The number of cases and estimated prevalence for 2012 only include cases up to the end of July. ‡ Population ﬁgures sourced from the Australian 
◆
2 Annual prevalence of microbiologically confirmed hookworm infection, by age 
group, and proportion of hookworm-positive faecal samples, Northern Territory, 
2002–2012*
* Data for 2012 only include cases up to the end of July. ◆
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Researchhave comorbidities. Current remote
practitioner guidelines recommend
performing faecal microscopy for chil-
dren with failure to thrive, anaemia or
chronic diarrhoea, and for adults who
are immunosuppressed.8 However,
there are several potential barriers to
testing patients in remote communi-
ties, including patient acceptability
and the geographical logistics of
ensuring a quality specimen reaches
the testing laboratory.
Some cases of HWI may have been
missed, as data were not available
from two providers of pathology serv-
ices to the NT. Nevertheless, for noti-
fiable diseases in the NT such as
hepatitis B, the government and
Western Diagnostic Pathology labora-
tories data capture over 90% of diag-
noses.16 We believe it is a reasonable
assumption that this will also be the
case for HWI. Patients residing in
remote areas were well represented in
the study population, and annual
numbers of faecal microscopy testing
were relatively constant over the 10
years. Thus, we are confident that the
consistent downward trend in preva-
lence demonstrated by our data
reflects a reduction in the true rate.
Finally, although we have shown that
most patients with HWI in the NT
had anaemia and/or eosinophilia,
community controls were not availa-
ble for comparison to support a caus-
ative association.
Our study, despite its limitations,
shows that the prevalence of HWI in
the NT decreased over a 10-year study
period. Infection was rare in children,
the target group for the longstanding
CCDP, but infection persists in Indige-
nous adults in remote communities
and those homeless in urban centres,
and in prisoners. This reflects, at least
in part, ongoing health and socioeco-
nomic inequalities in the Indigenous
population compared with non-Indig-
enous Australians. Our study supports
the need for continuation of the
CCDP, together with improvements in
housing, health hardware (such as
water supply and waste removal sys-
tems) and health promotion. It also
emphasises the importance of using
albendazole in children and adults
with anaemia and/or eosinophilia,
with the aim of eventual eradication of
human HWI from the NT.
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